 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Crystal structure of the complex between the mycobacterium beta-ketoacyl-acyl carrier protein synthase iii (fabh) and ss-(2-hydroxyethyl)-o-decyl ester carbono(dithioperoxoic) acid
|
|
Structure:
|
 |
3-oxoacyl-[acyl-carrier-protein] synthase 3. Chain: a, b. Synonym: 3-oxoacyl- [acyl-carrier-protein] synthase iii, beta-ketoacyl-acp synthase iii, kas iii, mtfabh. Engineered: yes
|
|
Source:
|
 |
Mycobacterium tuberculosis. Organism_taxid: 1773. Gene: fabh. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
2.30Å
|
R-factor:
|
0.170
|
R-free:
|
0.222
|
|
|
Authors:
|
 |
S.Sachdeva,F.Musayev,M.Alhamadsheh,J.N.Scarsdale,H.T.Wright, K.A.Reynolds
|
|
Key ref:
|
 |
S.Sachdeva
et al.
(2008).
Separate entrance and exit portals for ligand traffic in Mycobacterium tuberculosis FabH.
Chem Biol,
15,
402-412.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
19-Jul-07
|
Release date:
|
06-May-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P0A574
(FABH_MYCTU) -
3-oxoacyl-[acyl-carrier-protein] synthase 3
|
|
|
|
Seq: Struc:
|
 |
 |
 |
335 a.a.
330 a.a.
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.3.1.180
- Beta-ketoacyl-acyl-carrier-protein synthase Iii.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Acetyl-CoA + malonyl-[acyl-carrier-protein] = acetoacetyl-[acyl-carrier- protein] + CoA + CO2
|
 |
 |
 |
 |
 |
Acetyl-CoA
|
+
|
malonyl-[acyl-carrier-protein]
|
=
|
acetoacetyl-[acyl-carrier- protein]
|
+
|
CoA
|
+
|
CO(2)
Bound ligand (Het Group name = )
matches with 40.00% similarity
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
cytoplasm
|
1 term
|
 |
|
Biological process
|
metabolic process
|
5 terms
|
 |
|
Biochemical function
|
catalytic activity
|
9 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Chem Biol
15:402-412
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Separate entrance and exit portals for ligand traffic in Mycobacterium tuberculosis FabH.
|
|
S.Sachdeva,
F.N.Musayev,
M.M.Alhamadsheh,
J.N.Scarsdale,
H.T.Wright,
K.A.Reynolds.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Mycobacterium tuberculosis FabH initiates type II fatty acid synthase-catalyzed
formation of the long chain (C(16)-C(22)) acyl-coenzyme A (CoA) precursors of
mycolic acids, which are major constituents of the bacterial cell envelope.
Crystal structures of M. tuberculosis FabH (mtFabH) show the substrate binding
site to be a buried, extended L-shaped channel with only a single solvent access
portal. Entrance of an acyl-CoA substrate through the solvent portal would
require energetically unfavorable reptational threading of the substrate to its
reactive position. Using a class of FabH inhibitors, we have tested an
alternative hypothesis that FabH exists in an "open" form during substrate
binding and product release, and a "closed" form in which catalysis and
intermediate steps occur. This hypothesis is supported by mass spectrometric
analysis of the product profile and crystal structures of complexes of mtFabH
with these inhibitors.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
Y.Pérez-Castillo,
M.Froeyen,
M.A.Cabrera-Pérez,
and
A.Nowé
(2011).
Molecular dynamics and docking simulations as a proof of high flexibility in E. coli FabH and its relevance for accurate inhibitor modeling.
|
| |
J Comput Aided Mol Des, 25,
371-393.
|
 |
|
|
|
|
 |
C.A.Machutta,
G.R.Bommineni,
S.R.Luckner,
K.Kapilashrami,
B.Ruzsicska,
C.Simmerling,
C.Kisker,
and
P.J.Tonge
(2010).
Slow onset inhibition of bacterial beta-ketoacyl-acyl carrier protein synthases by thiolactomycin.
|
| |
J Biol Chem, 285,
6161-6169.
|
 |
|
|
|
|
 |
A.K.Bera,
V.Atanasova,
H.Robinson,
E.Eisenstein,
J.P.Coleman,
E.C.Pesci,
and
J.F.Parsons
(2009).
Structure of PqsD, a Pseudomonas quinolone signal biosynthetic enzyme, in complex with anthranilate.
|
| |
Biochemistry, 48,
8644-8655.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.M.Crawford,
T.P.Korman,
J.W.Labonte,
A.L.Vagstad,
E.A.Hill,
O.Kamari-Bidkorpeh,
S.C.Tsai,
and
C.A.Townsend
(2009).
Structural basis for biosynthetic programming of fungal aromatic polyketide cyclization.
|
| |
Nature, 461,
1139-1143.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.J.Lee,
J.B.Bhonsle,
H.W.Gaona,
D.P.Huddler,
T.N.Heady,
M.Kreishman-Deitrick,
A.Bhattacharjee,
W.F.McCalmont,
L.Gerena,
M.Lopez-Sanchez,
N.E.Roncal,
T.H.Hudson,
J.D.Johnson,
S.T.Prigge,
and
N.C.Waters
(2009).
Targeting the fatty acid biosynthesis enzyme, beta-ketoacyl-acyl carrier protein synthase III (PfKASIII), in the identification of novel antimalarial agents.
|
| |
J Med Chem, 52,
952-963.
|
 |
|
|
|
|
 |
Q.Al-Balas,
N.G.Anthony,
B.Al-Jaidi,
A.Alnimr,
G.Abbott,
A.K.Brown,
R.C.Taylor,
G.S.Besra,
T.D.McHugh,
S.H.Gillespie,
B.F.Johnston,
S.P.Mackay,
and
G.D.Coxon
(2009).
Identification of 2-Aminothiazole-4-Carboxylate Derivatives Active against Mycobacterium tuberculosis H(37)R(v) and the beta-Ketoacyl-ACP Synthase mtFabH.
|
| |
PLoS ONE, 4,
e5617.
|
 |
|
|
|
|
 |
S.Swanson,
K.Gokulan,
and
J.C.Sacchettini
(2009).
KasA, another brick in the mycobacterial cell wall.
|
| |
Structure, 17,
914-915.
|
 |
|
|
|
|
 |
E.Turos,
K.D.Revell,
P.Ramaraju,
D.A.Gergeres,
K.Greenhalgh,
A.Young,
N.Sathyanarayan,
S.Dickey,
D.Lim,
M.M.Alhamadsheh,
and
K.Reynolds
(2008).
Unsymmetric aryl-alkyl disulfide growth inhibitors of methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
|
| |
Bioorg Med Chem, 16,
6501-6508.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|